Responses
ARTICLE
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 23 November 2015
- Published on: 23 November 2015Use of nicotinic acid in JBS2Show More
Dear Editor,
With interest we read the new JSB guidelines but would like to clarify an issue relating to the correct licensed indication for nicotinic acid. Table 11 of the guidelines specifies that nicotinic acid be used in severe hypertriglyceridaemia with prior acute pancreatitis or not responsive to fibrates. The only formulation of nicotinic acid licensed for the treatment of dyslipidaemia is the prolonged re...
Conflict of Interest:
None declared.